Holding(s) in Company

RNS Number : 3294L
Venn Life Sciences Holdings PLC
08 January 2016
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Venn Life Sciences Holdings Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

Yes

Other (please specify):


No

3. Full name of person(s) subject to the
notification obligation:
iii

Livingbridge VC LLP

4. Full name of shareholder(s)
 (if different from 3.):iv

Baronsmead VCT plc    4.89%

Baronsmead VCT 2 plc 4.89%

Baronsmead VCT 3 plc 4.89%

Baronsmead VCT 4 plc 4.89%

Baronsmead VCT 5 plc 2.17%

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

12/10/2015

6. Date on which issuer notified:

22/10/2015

7. Threshold(s) that is/are crossed or
reached:
vi, vii

14%, 15%, 16%, 17%, 18%, 19%, 20% & 21%

 

 

 

 

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

Common Stock GBP

GB00B9275X97

 

 

5,263,157

 

13.42%



 

13,081,337


 

21.72%



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights





Nil


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

13,081,337

21.72%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

Livingbridge VC LLP

Baronsmead VCT plc    4.89%

Baronsmead VCT 2 plc 4.89%

Baronsmead VCT 3 plc 4.89%

Baronsmead VCT 4 plc 4.89%

Baronsmead VCT 5 plc 2.17%

 

Registered in the name of Chase Nominees Ltd


Proxy Voting:

10. Name of the proxy holder:

Livingbridge VC LLP

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A



13. Additional information:



14. Contact name:

Karen Huxley

15. Contact telephone number:

020 7506 5643



 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share


A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Venn Life Sciences Holdings Plc

Contact address

(registered office for legal entities)

 

4 Lombard Street

London

EC3V 9H2

Phone number & email

 

 

info@vlsworldwide.com

Tel: +31 (0) 524 712 456

Other useful information

(at least legal representative for legal persons)

 




B: Identity of the notifier, if applicable

Full name

 

Karen Huxley, Livingbridge VC LLP

Contact address

 

100 Wood Street, London, EC2V 7AN

Phone number & email

 

020 7506 5643

Karen.huxley@livingbridge.com

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)



C: Additional information


For notes on how to complete form TR-1 please see the FSA website.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEADFPESXKEFF

Companies

Hvivo (HVO)
UK 100

Latest directors dealings